Siegfried Holding AG has attributed a surge in API sales to the drug ingredients business it bought from BASF last year, but says that integration costs hurt profits.
BASF says it remains committed to the pharma industry despite plans to divest its custom synthesis business and around 100 APIs and intermediates to Siegfried Holding.
The amines market will grow 5% over the next decade according to BASF, which cited rising drugmaker demand as a key driver for its investment in a new German plant.
Omega-3 supplier BASF will continue to produce the API for Amarin, as well as its competitor GlaxoSmithKline, despite an FDA panel saying that Amarin’s drug should not be approved for a broader population.
BASF has raised its prices for three ethanolamines (EOA), key intermediates in the production of a wide range of active pharmaceutical ingredients (API).
German chemical giant BASF chose this year’s AAPS meeting in Atlanta, US to showcase its growing library of USP excipient verification certificates, making good on its commitment to apply the highest manufacturing standards to this area of its business.
German chemicals giant BASF has announced its latest brace of price
rises, this time for two forms of carboxylic acid and for bleaching
and reducing agents.
In this week's review of activity within the preclinical research
services arena, new deals have emerged involving Gene Bridges,
Panacos Pharmaceuticals, and GenScript.
BASF is boosting by 30,000 tons its annual production capacity for
the chemical intermediate tetrahydrofuran (THF) at the group's site
in Ludwigshafen, Germany.
Almost 130 jobs will be lost at BASF's Minden site as the company
succumbs to growing pressure from the Asian generic active
pharmaceutical ingredient (API) market.
In an attempt to counter competition in generic active
pharmaceutical ingredients (APIs) from Asian manufacturers, BASF
has decided to downscale production at its Minden production site,
implementing a restructuring programme that...
BASF is targeting the pharma industry at ChemSpec this June with
new intermediates, catalysts and raw materials that promise to make
customers' syntheses less complex and time-consuming as well as
more cost-effective.
German chemicals giant BASF saw its profits surge in the first
quarter of 2006 on the back of high oil and gas prices, yet its
fine chemicals unit was hit by the increased cost of raw materials
and energy, making further price increases...
Chemical manufacturing giant BASF is building an alkylethanolamine
(AEOA) plant at its US site in Louisiana, as increasing American
demand pushes the company to increase worldwide production
capacities for these important intermediates...
Chemical company BASF has developed a process for the production of
new chiral intermediates for the pharmaceutical industry on a
commercial scale, further raising the product efficiency of drugs
and reducing undesirable effects.
After months of speculation, chemical giants BASF have put in a
$4.9 billion (€4.1 billion) offer for the Engelhard Corporation,
which if successful, would become BASF's largest acquisition to
date, surpassing Dow Chemical as...
BASF has announced that it is to raise prices of its pharmaceutical
excipients in a move that represents the wider market that has seen
big cost increases for raw materials, energy and transportation
that has affected all excipient...
BASF launched its new dry binder excipient at CPhI, aimed at
increasing the hardness of pharmaceutical tablets and reducing the
manufacturing costs associated with damaged and broken tablets.
BASF, the world's largest chemical company, and Seppic, an offshoot
of Air Liquide Healthcare, have embarked on a strategic cooperation
to jointly develop and market coating systems for film coating of
tablets in the drug industry.
German chemicals giant BASF reported strong earnings increases
across the board yesterday, helped by pricing increases. The
companies activities in pharmaceuticals, part of its chemicals and
fine chemicals units, also did well, report...
German chemicals group BASF has launched two new pharmaceutical
film-coating products, cementing its position in a market estimated
to be worth about €200 million and growing at 5 to 6 per cent a
year.
BASF has threatened to relocate research into 'green genetic
engineering' to other countries if German law continues to restrict
R&D into plant biotechnology, with applications as diverse as
crop biomanufacturing of...
Chemical giant BASF has increased the price of its styrene polymers
Polystyrene (PS), Terluran (ABS) and Luran (SAN) by €250 per metric
ton in Europe as of 1 September, blaming a continuing erosion in
margins caused by further increases...
BASF has officially inaugurated a new production plant for the fine
chemicals intermediate citral at its Ludwigshafen site in Germany.
The world-scale plant, which has an annual capacity of 40,000
metric tons, replaces an existing...
The German chemicals giant BASF has announced a successful second
quarter, though the company's nutrition and agricultural products
division turned in a poor performance with minimal sales growth and
reduced earnings from the...
Chemical giant BASF is set to raise its European price for
polystyrene (PS) by €200 per metric ton from 1 July this year in
response to what it calls totally unsatisfactory margins and
earnings.
BASF and Merck KGaA have joined DSM in reporting encouraging
first-quarter 2004 results, raising hopes further that the European
chemicals sector may be about to move into recovery mode, writes
Phil Taylor.
German chemicals giant BASF has beaten its own sales and earnings
forecasts for 2003, prompting chairman Jurgen Hambrecht to suggest
that the sector may be due for something of a recovery this year,
writes Phil Taylor.
BASF has claimed a first with the launch of a new pellet form of
triphenylphosphine (TPP), used in the production of active
pharmaceutical ingredients, that minimises dust and improves
handling and processing.
BASF IT Services, one of the first units of the German chemical
major to be spun out into a separate unit, has signed an agreement
with Merck KGaA that confirms its ability to win major contracts
from companies other than its parent.
Chemicals major BASF managed to post a small gain in third quarter
revenues despite the difficult operating environment affecting the
industry; chairman Hambrecht points to early signs that the sector
may have hit bottom and be ready...
Process manufacturing industries are not responding to a clear need
to improve the information flow between the different parts of
their businesses leading to costly plant shutdowns, says a new
survey commissioned by BASF IT Services.
BASF has started work on a combined heat and power plant at its
site in Ludwigshafen that will help the company meet its long-term
environmental targets.
BASF has completed a production plant for high-purity
methanesulfonic acid, widely used in the chemical industry and in
the synthesis of pharmaceuticals.
